Stage IVB Rectal Cancer Terminated Phase 2 Trials for Oxaliplatin (DB00526)

IndicationStatusPhase
DBCOND0028589 (Stage IVB Rectal Cancer)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01320683Combination Chemotherapy and Bevacizumab Before Surgery and Radiolabeled Monoclonal Antibody Therapy in Treating Liver Metastases in Patients With Metastatic Colorectal CancerTreatment